Potential therapeutic options for COVID-19: an update on current evidence

Z Niknam, A Jafari, A Golchin, F Danesh Pouya… - European journal of …, 2022 - Springer
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

Mesenchymal stem cell therapy for COVID-19: present or future

A Golchin, E Seyedjafari, A Ardeshirylajimi - Stem cell reviews and reports, 2020 - Springer
Abstract “COVID-19” is the word that certainly isn't forgotten by everybody who lives in the
first half of the twenty-first century. COVID-19, as a pandemic, has led many researchers …

The approved gene therapy drugs worldwide: from 1998 to 2019

CC Ma, ZL Wang, T Xu, ZY He, YQ Wei - Biotechnology advances, 2020 - Elsevier
With the improvement of gene vectors, the rise of chimeric antigen receptor T cell
immunotherapy and breakthroughs in the genome editing technology, gene therapy had …

[HTML][HTML] Cell therapy: types, regulation, and clinical benefits

AEH El-Kadiry, M Rafei, R Shammaa - Frontiers in Medicine, 2021 - frontiersin.org
Cell therapy practices date back to the 19th century and continue to expand on
investigational and investment grounds. Cell therapy includes stem cell-and non–stem cell …

Recent trends in cancer therapy: A review on the current state of gene delivery

EB Yahya, AM Alqadhi - Life Sciences, 2021 - Elsevier
Cancer treatment has been always considered one of the most critical and vital themes of
clinical issues. Many approaches have been developed, depending on the type and the …

COVID-19 Creating another problem? Sustainable solution for PPE disposal through LCA approach

H Kumar, A Azad, A Gupta, J Sharma… - Environment …, 2021 - Springer
Amid COVID-19, there have been rampant increase in the use of Personal Protective
Equipment (PPE) kits by frontline health and sanitation communities, to reduce the …

Recent advances in enabling technologies in 3D printing for precision medicine

ME Prendergast, JA Burdick - Advanced Materials, 2020 - Wiley Online Library
Advances in areas such as data analytics, genomics, and imaging have revealed individual
patient complexities and exposed the inherent limitations of generic therapies for patient …

[HTML][HTML] Combating COVID-19 with mesenchymal stem cell therapy

K Rajarshi, A Chatterjee, S Ray - Biotechnology reports, 2020 - Elsevier
The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The
virus mainly targets the pulmonary epithelial cells as it's initial site of infection by letting its …

Biomaterials for in situ cell therapy

C Wang, S Wang, DD Kang, Y Dong - BMEMat, 2023 - Wiley Online Library
Cell therapy has revolutionized the treatment of various diseases, such as cancers, genetic
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …

Cell-based therapy for severe COVID-19 patients: clinical trials and cost-utility

A Golchin - Stem cell reviews and reports, 2021 - Springer
The race among countries and companies to develop efficacious vaccines and therapeutics
for the COVID-19 is ongoing fast, with many trials underway. Among this, cell-based therapy …